Orthocell Statistics
Total Valuation
Orthocell has a market cap or net worth of AUD 338.77 million. The enterprise value is 308.58 million.
Market Cap | 338.77M |
Enterprise Value | 308.58M |
Important Dates
The next estimated earnings date is Friday, May 23, 2025.
Earnings Date | May 23, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Orthocell has 241.98 million shares outstanding. The number of shares has increased by 4.09% in one year.
Current Share Class | n/a |
Shares Outstanding | 241.98M |
Shares Change (YoY) | +4.09% |
Shares Change (QoQ) | +6.48% |
Owned by Insiders (%) | 20.40% |
Owned by Institutions (%) | 2.07% |
Float | 191.25M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 53.64 |
PB Ratio | 17.25 |
P/TBV Ratio | 18.21 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -95.04 |
EV / Sales | 48.87 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -38.26 |
Financial Position
The company has a current ratio of 7.53, with a Debt / Equity ratio of 0.03.
Current Ratio | 7.53 |
Quick Ratio | 7.30 |
Debt / Equity | 0.03 |
Debt / EBITDA | n/a |
Debt / FCF | -0.08 |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -29.77% and return on invested capital (ROIC) is -56.81%.
Return on Equity (ROE) | -29.77% |
Return on Assets (ROA) | -20.32% |
Return on Invested Capital (ROIC) | -56.81% |
Return on Capital Employed (ROCE) | -30.01% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.19 |
Inventory Turnover | 1.92 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +273.33% in the last 52 weeks. The beta is 0.39, so Orthocell's price volatility has been lower than the market average.
Beta (5Y) | 0.39 |
52-Week Price Change | +273.33% |
50-Day Moving Average | 1.38 |
200-Day Moving Average | 0.94 |
Relative Strength Index (RSI) | 52.17 |
Average Volume (20 Days) | 2,421,029 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Orthocell had revenue of AUD 6.31 million and -3.25 million in losses. Loss per share was -0.02.
Revenue | 6.31M |
Gross Profit | 4.23M |
Operating Income | -10.56M |
Pretax Income | -9.48M |
Net Income | -3.25M |
EBITDA | -10.18M |
EBIT | -10.56M |
Loss Per Share | -0.02 |
Balance Sheet
The company has 30.84 million in cash and 657,928 in debt, giving a net cash position of 30.18 million or 0.12 per share.
Cash & Cash Equivalents | 30.84M |
Total Debt | 657,928 |
Net Cash | 30.18M |
Net Cash Per Share | 0.12 |
Equity (Book Value) | 19.64M |
Book Value Per Share | 0.08 |
Working Capital | 31.70M |
Cash Flow
In the last 12 months, operating cash flow was -7.34 million and capital expenditures -725,055, giving a free cash flow of -8.06 million.
Operating Cash Flow | -7.34M |
Capital Expenditures | -725,055 |
Free Cash Flow | -8.06M |
FCF Per Share | -0.03 |
Margins
Gross margin is 67.04%, with operating and profit margins of -167.21% and -51.42%.
Gross Margin | 67.04% |
Operating Margin | -167.21% |
Pretax Margin | -150.17% |
Profit Margin | -51.42% |
EBITDA Margin | -161.18% |
EBIT Margin | -167.21% |
FCF Margin | n/a |
Dividends & Yields
Orthocell does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -4.09% |
Shareholder Yield | -4.09% |
Earnings Yield | -0.96% |
FCF Yield | -2.38% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Orthocell has an Altman Z-Score of 1.03. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.03 |
Piotroski F-Score | n/a |